Facebook
Tri City CardiologyTri City Cardiology
Tri City Cardiology
Leaders in Cardiovascular Excellence

Phone: 480-835-6100
Fax: 480-461-4243

  • Home
  • Our Practice
    • Locations & Affiliations
    • New Patient Forms
    • Accepted Insurances
    • Make a Payment
    • Patient Portal
  • Our Services
    • Medical Cardiology
    • Diagnostic Testing
    • Interventional Cardiology
    • Electrophysiology
    • Peripheral Vascular
    • Vein Center
    • Disease Management
  • Our Providers
    • Physicians
      • Mark S. Stern, M.D.
      • David M. Kassel, M.D.
      • Thomas A. Ritchie, M.D.
      • James J. Del Giorno, M.D.
      • Duane W. Heinrichs, M.D.
      • Arman Talle, M.D.
      • Jaskamal Kahlon, M.D.
      • Joshua D. Cohen, M.D.
      • M. Joshua Berkowitz, M.D.
      • Kai Sung, M.D.
      • Arun K. Kolli, M.D.
      • Satya R. Atmakuri, M.D.
      • Jacob Green, M.D.
      • Loan Linda Nguyen, M.D.
      • Todd S. Perlstein, M.D.
      • Praneet K. Sharma, M.D.
      • Sreedivya Chava, M.D.
      • Kelly E. Guld, M.D.
      • Craig D. Robison, M.D.
      • Ephraim Weiss, M.D.
      • Camille Phuc Le, MD, FACC
    • Nurse Practitioners
      • Jodie J. Brasfield, ACNP-c
      • Weston W. Sanders, FNP-C
      • Alisha Zimmer, MSN, FNP-C, AACC, CCRN
      • Kristina D. Bardwell, ACNP-BC
      • Nicole Jones, AG-ACNP
      • Kim Buckley, FNP, ANCC
      • Alyssa Smith, DNP
      • Michael C Smith, PA-C
  • Referring Physicians
  • Events and News
    • Events
    • News
    • Video Library
    • Newsletter
    • Blog
  • Career Opportunities
    • Career Opportunities
    • Physician Career Opportunities
  • Testimonials
    • Read Patient Testimonials
    • Add Testimonial
  • Contact Us
    • Patient Forms
    • Make a Payment
    • Patient Portal
Menu back  

Thomas A. Ritchie, M.D., FACC

Specialties:

Cardiology, Cardiovascular Disease

480-835-6100

Dr. Thomas A. Ritchie is Board Certified in Cardiovascular Disease, Nuclear Cardiology, and Internal Medicine. He completed his Fellowship in Cardiology and Residency in Internal Medicine through Emory University Affiliated Hospitals. Prior to earning his Doctorate of Medicine from Emory University, Dr. Ritchie graduated Cum Laude from the University of Georgia with a Bachelor of Science in Microbiology. Dr. Ritchie is a Fellow of the American College of Cardiology.

Locations

Tri-City Cardiology – Baywood

6750 E. Baywood Ave., Suite 301, Mesa, AZ 85206

480-835-6100

Tri-City Cardiology – Gilbert

3530 S. Val Vista Dr., Suite 103, Gilbert, AZ 85297

480-835-6100

Education/Training

Medical School - Emory University School of Medicine, Alanta, GA

Internship - Emory University Hospital, Atlanta, GA

Residency - Emory University Affiliated Hospitals, Altanta, GA

Fellowship - Emory University Affiliated Hospitals, Atlanta, GA

Recognition/Research/Publications

Recognition:

  • Phoenix magazine’s “Top Docs” in Cardiology in 2006, 2007, 2008, 2010, 2015.
  • Elected by his peers for inclusion in Best Doctors in America 2005-2016.
  • Alpha Omega Alpha National Honor Medical Society – Emory University School of Medicine.
  • Phi Beta Kappa – University of Georgia.
  • Press Ganey, a renowned research firm, ranks him in the top 10th percentile of physicians in the country whose patients would recommend him as a physician to friends and family.

Research:

  • 2000 to Current: SPORTIF V – An Efficacy and Safety Study of the Oral Direct Thrombin Inhibitor H 376/95 Compared with Dose-Adjusted Warfarin (Coumadin®) in the Prevention of Stroke and Systemic Embolic Events in patients with Atrial Fibrillation. Sub-Investigator.
  • 1999 to Current: VALIANT Trial – Valsartan In Acute Myocardial Infarction Trial. A multinational, double-blind, randomized, active controlled, parallel group study comparing the efficacy and safety of long-term treatment with valsartan, captopril and their combination in high risk patients after myocardial infarction. Sponsored by Novartis Pharmaceuticals Corporation. Sub-Investigator.
  • 1999 to Current: GUSTO IV AMI Trial – A Phase III Randomized, Open-Label Trial Evaluating The Efficacy And Safety Of ReoPro7 (Abciximab) In Combination With Reduced Dose Retavase7/RapilysinJ (Recombinant Plasminogen Activator, Reteplase, r-PA) For The Treatment Of Acute Myocardial Infarction. Sub-Investigator.
  • 1996: “Pulmonary Hypertension in Patients with Dilated Cardiomyopathy” under Andrew Smith, M.D. Emory University.
  • 1986: “Characterization of a Plasmid as a Cloning Vector” under William Finnerty, Ph.D.University of Georgia.
  • 1988: “Evaluation of a Hospital’s Quality Assurance Program: Impact on Patient Care” under Joe Boone, Ph.D. Centers for Disease Control.

Publications:

  • 1992: CNN Healthweek Program Interview.
  • 1993: “Myocardial Infarction due to Pheochromocytoma” Associates Scientific Sessions American College of Physicians.

 

2015-2016

*Elected by his peers for inclusion in Best Doctors in America® from 2005 to 2016

Copyright ©2016 Tri-City Cardiology | Privacy Policy | Legal Notices & Disclaimers


Online Medical Marketing by MD Connect inc